Monday, 3 July 2017

Antibiotic shortage puts patients at risk, doctors fear

Antibiotic shortage puts patients at risk, doctors fear Exclusive: supply problems with one of most widely used drugs mean doctors are being forced to ration its use and switch to less desirable alternatives

A major shortage of one of the most widely used hospital antibiotics is putting patients at risk, doctors have warned.

There is an international shortage of of piperacillin-tazobactam, an antibiotic and antibacterial combination drug known by the trade name Tazocin, which is usually used intravenously in intensive care. It is also used to treat a wide variety of conditions including cystic fibrosis, pneumonia, urinary tract infections, diabetic foot infections and neutropenic sepsis – a life-threatening condition that can arise in those receiving anti-cancer treatment. Continue reading... The Guardian

No comments:

Post a Comment